Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
BNC Korea Co., Ltd. engages in the research and development, production, and sale of biomaterials in South Korea. The company offers HA fillers and skin booster fillers, including Cutegel, Cutegel Lidocaine, FLORE Lidocaine, ChungA-an, CUTEGEL-M, Cutegel Hydro, S-DNA, and H-DNA, which are used to temporarily reduce facial wrinkles through physical restoration. It also provides Hibarry, a dressing for deep-cavity wounds that is used to reduce adhesion of the spinal cord during surgery; GENTA Q, a white collagen sponge, which is used to protect wounds by preventing contamination of wounds; and beauty solutions, face mask gels, mils cleansing foams, and brightening peeling gels. The company also exports its products to 45 countries. BNC Korea Co., Ltd. was founded in 2007 and is headquartered in Daegu, South Korea.
Company Valuation
Considering past and projected metrics, the stock is slightly 'cheaper' than its peers. Specifically, the stock is fairly valued on P/E, undervalued on EV/EBITD.
Buy
Sell